Developing Lectins as Inhibitors of Coronavirus Spike Proteins
Developing Lectins as Inhibitors of Coronavirus Spike Proteins
批准号:
10428203
负责人:
Alex Joseph Guseman
金额:
$10.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-01 至 2024-08-31
关键词:
2019-nCoVACE2Animal ModelAntibodiesAwardBindingBiochemicalBiological AssayBiophysicsBurkholderiaCOVID-19COVID-19 vaccineCellsCessation of lifeClinicCommunicationCoronavirusCoronavirus spike proteinDangerousnessDataDevelopmentDevelopment PlansDiagnosticDiseaseEducational workshopElectron MicroscopyFDA Emergency Use AuthorizationFamilyFutureGlycoproteinsGrantHIVHealthHealth PersonnelHumanImmuneIncentivesInfectionInterventionKnowledgeLeadLectinLeftLiliumLinkMannoseMediatingMembrane FusionMentorshipMiddle East Respiratory Syndrome CoronavirusMolecular ConformationMolecular Sieve ChromatographyMutationPharmacologic SubstancePhasePolysaccharidesProcessProteinsResearchResourcesRespiratory DiseaseRiskSARS coronavirusSARS-CoV-2 infectionSARS-CoV-2 inhibitorSARS-CoV-2 spike proteinSARS-CoV-2 variantScienceSolventsSpanish fluSpecificityStructureSurfaceTestingTherapeuticTherapeutic antibodiesTrainingTreatment EfficacyUniversitiesVaccinationVaccine ResearchVaccinesVariantViralViral GenomeVirionVirusVirus DiseasesWorkWritingbetacoronaviruscarbohydrate binding proteincareercareer developmentcombatconvalescent plasmadesignexperimental studyfight againstglycosylationgp-120 Antigenhuman coronavirusinhibitorinstrumentationknowledge of resultslight scatteringmembernanomolarneutralizing antibodynovelnovel coronaviruspandemic diseasepreventreceptorreceptor bindingskillsstructural biologysymposiumvariants of concernviral entry inhibitorvirologyweapons
中文摘要
项目摘要/摘要
2019年末,SARS-CoV2病毒以全球大流行的形式出现,导致严重的呼吸道疾病
新冠肺炎,并导致全球数以百万计的人死亡。作为一种冠状病毒,SARS-CoV2宿主相互作用是
通过包围病毒粒子的刺突蛋白口述。SARS-CoV2的刺突蛋白是一种高度
糖基化三聚体,通过受体结合域(RBD)与宿主细胞上的ACE2受体相互作用
以便于病毒进入。作为病毒感染的关键角色,Spike三聚体和RBD已成为攻击目标
用于治疗或预防SARS-CoV2的大多数已获批准的疗法和疫苗。在这项提案中,
Pi使用了一种新型的抗病毒凝集素BOA,他已经证明BOA能将多糖结合到Spike蛋白上,
并抑制SARS-CoV2病毒进入。为了了解BOA是如何抑制病毒进入的,在K99阶段
获奖后,PI将确定BOA通过使用一种
病毒抑制试验、生物物理试验和电子显微镜相结合。随后,PI将
测试BOA抑制新出现的令人担忧的SARS-CoV2变异的能力,这些变异累积到
促进免疫逃逸的尖峰蛋白的不同区域。在这些发现的基础上,在
这个奖项的独立R00阶段,PI将使用在K99阶段培养的技能来建立HIS
自己的独立研究小组,在那里他们将测试BOA凝集素抑制Beta-
已知会感染人类的冠状病毒。成功地完成这些目标可以提供真正广泛的
冠状病毒光谱抑制剂将进一步开发用于治疗或诊断下一种冠状病毒
这就浮现出来了。拟议的研究将为PI提供新的和令人兴奋的病毒学培训以及
电子显微镜,他打算把它传给他未来的实习生。拟议的工作将于
匹兹堡大学,结构生物系和疫苗研究中心将在那里
提供无与伦比的资源、仪器和该领域专家的访问。私家侦探已经组装了一个
由病毒学家和生物物理学家组成的令人兴奋的指导团队,他将每月与他们会面,接受建议,
讨论结果,设计新的实验,为过渡到独立的职业生涯做好准备。协助
在他的职业发展过程中,该大学提供了许多研讨会来培养他的技能,如撰写拨款
和导师关系。PI还将出席会议,发表演讲并磨练他的科学
沟通技巧。总之,拟议的培训和职业发展计划将使专业人员做好准备
领导自己的独立研究小组,成为他所在领域的领导者。
英文摘要
Project Summary/Abstract
In late 2019, the SARS-CoV2 virus emerged as a global pandemic, causing the severe respiratory disease
COVID-19 and resulting in millions of deaths worldwide. As a coronavirus, SARS-CoV2 host interactions are
dictated through the Spike proteins that encompass the virion. The Spike protein of SARS-CoV2, is a highly
glycosylated trimer that interacts with the ACE2 receptor on host cells via the receptor binding domain (RBD)
to facilitate viral entry. As a key player in viral infection, the Spike trimer, and the RBD, have become the target
for a majority of approved therapeutics and vaccines used to treat or prevent SARS-CoV2. In this proposal, the
PI uses a novel antiviral lectin, BOA, which he has demonstrated that BOA binds glycans on the spike protein,
and inhibits SARS-CoV2 viral entry. To understand how BOA inhibits viral entry, during the K99 phase of the
award, the PI will determine the mechanism by which BOA inhibits in SARS-CoV2 viral infection using a
combination of viral inhibition assays, biophysical assays, and electron microscopy. Subsequently the PI will
test the ability of BOA to inhibit emerging SARS-CoV2 variants of concern that have accumulated mutations to
various regions of the spike protein that facilitate immune escape. Expanding upon these findings during the
independent R00 phase of this award, the PI will use skills developed during the K99 phase to establish his
own independent research group, where they will test the ability of the BOA lectin to inhibit viral entry of Beta-
Coronaviruses known to infect humans. Successful completion of these aims could provide a bona fide broad
spectrum coronavirus inhibitor to be further developed as a therapeutic or diagnostic for the next coronavirus
that emerges. The proposed research, will provide the PI with new and exciting training in virology as well as
electron microscopy which he intends to pass on to his future trainees. The proposed work will be completed at
The University of Pittsburgh, where the Department of Structural Biology and Center for Vaccine Research will
provide unmatched access to resources, instrumentation, and experts in the field. The PI has assembled an
exciting mentorship team of virologists and biophysicists who he will meet with monthly to receive advice,
discuss results, designed new experiments, and prepare for transitioning into an independent career. To aide
in his career development, the university offers numerous workshops to develop skills such as grant writing
and mentorship. The PI will also attend conferences to give presentations and hone his science
communications skills. In Summary, the proposed training and career development plans will prepare the PI to
lead his own independent research group and become a leader in his field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位:
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
-
批准号:82305216
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:姚骏凯
-
依托单位:
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
-
批准号:32302080
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋田源
-
依托单位:
感毒清经ACE2/Ang(1-7)/MasR信号通路抑制PM2.5诱导慢性气道炎症的机制:聚焦肺泡巨噬细胞极化与“胞葬”的表型串扰
-
批准号:82305171
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:吴永灿
-
依托单位: